KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Aurinia Pharmaceuticals (AUPH) Amortization - Deferred Charges: 2014-2020

Historic Amortization - Deferred Charges for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Sep 2020 value amounting to -$29,000.

  • Aurinia Pharmaceuticals' Amortization - Deferred Charges fell 196.67% to -$29,000 in Q3 2020 from the same period last year, while for Sep 2020 it was -$58,000, marking a year-over-year decrease of 148.74%. This contributed to the annual value of -$168,000 for FY2016, which is 22.94% up from last year.
  • Aurinia Pharmaceuticals' Amortization - Deferred Charges amounted to -$29,000 in Q3 2020, which was down 0.00% from -$29,000 recorded in Q2 2020.
  • Aurinia Pharmaceuticals' Amortization - Deferred Charges' 5-year high stood at $30,000 during Q1 2018, with a 5-year trough of -$30,000 in Q1 2020.
  • Its 3-year average for Amortization - Deferred Charges is $10,000, with a median of $29,000 in 2019.
  • Data for Aurinia Pharmaceuticals' Amortization - Deferred Charges shows a maximum YoY tumbled of 200.00% (in 2020) over the last 5 years.
  • Over the past 3 years, Aurinia Pharmaceuticals' Amortization - Deferred Charges (Quarterly) stood at $30,000 in 2018, then remained steady at $30,000 in 2019, then plummeted by 196.67% to -$29,000 in 2020.
  • Its Amortization - Deferred Charges was -$29,000 in Q3 2020, compared to -$29,000 in Q2 2020 and -$30,000 in Q1 2020.